ProShare Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
75,068
+3,183
| +4% | +$87.8K | ﹤0.01% | 685 |
|
|
2025
Q1 | $2.04M | Buy |
71,885
+1,632
| +2% | +$46.3K | ﹤0.01% | 672 |
|
|
2024
Q4 | $2.92M | Sell |
70,253
-359,045
| -84% | -$14.9M | 0.01% | 619 |
|
|
2024
Q3 | $28.7M | Buy |
429,298
+27,750
| +7% | +$1.85M | 0.07% | 224 |
|
|
2024
Q2 | $47.7M | Sell |
401,548
-43,073
| -10% | -$5.11M | 0.13% | 142 |
|
|
2024
Q1 | $47.4M | Buy |
444,621
+78,017
| +21% | +$8.31M | 0.13% | 148 |
|
|
2023
Q4 | $36.5M | Sell |
366,604
-61,975
| -14% | -$6.16M | 0.11% | 173 |
|
|
2023
Q3 | $44.3M | Buy |
428,579
+53,937
| +14% | +$5.57M | 0.14% | 135 |
|
|
2023
Q2 | $45.5M | Sell |
374,642
-29,289
| -7% | -$3.56M | 0.13% | 132 |
|
|
2023
Q1 | $62M | Buy |
403,931
+37,368
| +10% | +$5.74M | 0.19% | 114 |
|
|
2022
Q4 | $65.8M | Sell |
366,563
-51,985
| -12% | -$9.34M | 0.23% | 102 |
|
|
2022
Q3 | $49.5M | Sell |
418,548
-83,002
| -17% | -$9.81M | 0.19% | 108 |
|
|
2022
Q2 | $71.6M | Sell |
501,550
-260,438
| -34% | -$37.2M | 0.24% | 107 |
|
|
2022
Q1 | $131M | Sell |
761,988
-28,621
| -4% | -$4.93M | 0.28% | 102 |
|
|
2021
Q4 | $201M | Buy |
790,609
+246,204
| +45% | +$62.5M | 0.39% | 50 |
|
|
2021
Q3 | $210M | Buy |
544,405
+87,676
| +19% | +$33.7M | 0.59% | 26 |
|
|
2021
Q2 | $107M | Sell |
456,729
-9,111
| -2% | -$2.14M | 0.31% | 102 |
|
|
2021
Q1 | $61M | Buy |
465,840
+70,703
| +18% | +$9.26M | 0.19% | 127 |
|
|
2020
Q4 | $41.3M | Buy |
395,137
+50,961
| +15% | +$5.32M | 0.15% | 141 |
|
|
2020
Q3 | $24.4M | Buy |
344,176
+277,285
| +415% | +$19.6M | 0.11% | 159 |
|
|
2020
Q2 | $4.3M | Buy |
66,891
+17,274
| +35% | +$1.11M | 0.02% | 422 |
|
|
2020
Q1 | $1.49M | Sell |
49,617
-27,384
| -36% | -$820K | 0.01% | 526 |
|
|
2019
Q4 | $1.51M | Buy |
+77,001
| New | +$1.51M | 0.01% | 681 |
|